Litcius/Paper detail

<scp>NMDAR</scp> Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice

Marc Carceles‐Cordon, Francesco Mannara, Esther Aguilar, Aida Castellanos, Jesús Planagumà, Josep Dalmau

2020Annals of Neurology61 citationsDOI

Abstract

OBJECTIVE: The aim was to demonstrate that antibodies from patients with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis alter the levels of dopamine 1 receptor (D1R) and dopamine 2 receptor (D2R) and cause psychotic-like features in mice. METHODS: Cultured rat hippocampal neurons were treated with cerebrospinal fluid (CSF) from patients with anti-NMDAR encephalitis or controls, and the effects on clusters of D1R and D2R were quantified. In vivo studies included 71 C57BL/6J mice that were chronically infused with CSF from patients or controls through ventricular catheters connected to subcutaneous osmotic pumps. Prepulse inhibition of the acoustic startling reflex (PPI; a marker of psychotic-like behavior), memory, locomotor activity, and the density of cell-surface and synaptic D1R, D2R, and NMDAR clusters were examined at different time points using reported techniques. RESULTS: In cultured neurons, CSF from patients, but not from controls, caused a significant decrease of cell-surface D1R and an increase of D2R clusters. In mice, CSF from patients caused a significant decrease of synaptic and total cell-surface D1R clusters and an increase of D2R clusters associated with a decrease of PPI. These effects were accompanied by memory impairment and a reduction of surface NMDARs, as reported in this model. The psychotic-like features, memory impairment, and changes in levels of D1R, D2R, and NMDAR progressively improved several days after the infusion of CSF from patients stopped. INTERPRETATION: In addition to memory deficits and reduction of NMDARs, CSF antibodies from patients with anti-NMDAR encephalitis cause reversible psychotic-like features accompanied by changes (D1R decrease, D2R increase) in cell-surface dopamine receptor clusters. ANN NEUROL 2020 ANN NEUROL 2020;88:603-613.

Topics & Concepts

Dopamine receptor D2NMDA receptorDopamineCerebrospinal fluidInternal medicinePrepulse inhibitionHippocampal formationReceptorEndocrinologyNeuroscienceChemistryMedicinePsychologySchizophrenia (object-oriented programming)PsychiatryAutoimmune Neurological Disorders and TreatmentsGenetic Neurodegenerative DiseasesMultiple Sclerosis Research Studies